Skip to main content

Advertisement

Table 1 Serology titres and perinatal complications of 19 women with Q fever among 179 pregnant women with adverse pregnancy outcomes (APO), Saint Pierre, May to October 2013

From: Pregnancy outcomes of Q fever: prospective follow-up study on Reunion island

PatientAge range (years)Phase 2 IgMPhase 2 IgGPhase 1 IgGAPO (weeks)
135 to 40482560LPTB (36 weeks)
231 to 35962560EM (9 weeks)
315 to 200640SGA + OA (39 weeks)
431 to 3501280EM (10 weeks)
521 to 251921024128EM (5 weeks)
641 to 450512128EM (8 weeks)
721 to 2502560NGA (39 weeks)
826 to 30010240EM (8 weeks)
936 to 4002560HM + EM (8 weeks)
1016 to 2002560IUFD+LPTB(36 weeks)
1116 to 200640EM (6 weeks)
1231 to 350640LM (21 weeks)
1316 to 200640LPTB+SGA (36 weeks)
1441 to 4501280EM (9 weeks)
1531 to 3502560IUFD+VPTB (32 weeks)
1636 to 4001280EM (9 weeks)
1726 to 300640VPTB+SGA (31 weeks)
1836 to 4002560SGA (39 weeks)
1921 to 2501280SGA (37 weeks)
  1. EM early miscarriage (aka spontaneous abortion< 12 weeks of gestation), HM hydatiform mole, LM late miscarriage (aka, spontaneous abortion 12 to 21 weeks, or birthweight< 500 g.), IUFD intrauterine foetal death (aka stillbirth, ≥ 22 weeks or birthweight ≥500 g.), VPTB very preterm birth (22 to 32 weeks), LPTB late preterm birth (33 to 36 weeks), NGA normal for gestational age, SGA small for gestational age (intrauterine growth restriction; birthweight <10th percentile), OA oligohydramnios